ERBB2 and sarcoma: In a phase I/II clinical study using T-cells expressing human epidermal growth factor 2 (HER2)-specific chimeric antigen receptor (HER2-CAR T-cells), 19 patients with HER2-positive sarcomas underwent HER2-CAR T-cell therapy [100].